PTEN and hepatocellular carcinoma: Therefore, we developed an RNA aptamer-mediated targeting drug delivery system with Ad5-PTEN to overcome the non-selectivity and non-specificity of Ad5-PTEN, reduce the toxicity against normal cells, and enhance the antitumor effect on human HCC.